Found: 21
Select item for more details and to access through your institution.
Pharmacodynamic Modeling to Evaluate the Impact of Cimetidine, an OCT2 Inhibitor, on the Anticancer Effects of Cisplatin.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 1, p. 57, doi. 10.3390/cells12010057
- By:
- Publication type:
- Article
In vitro to clinical translation of combinatorial effects of doxorubicin and dexrazoxane in breast cancer: a mechanism-based pharmacokinetic/pharmacodynamic modeling approach.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1239141
- By:
- Publication type:
- Article
A Review on Drug‐Induced Nephrotoxicity: Pathophysiological Mechanisms, Drug Classes, Clinical Management, and Recent Advances in Mathematical Modeling and Simulation Approaches.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 896, doi. 10.1002/cpdd.879
- By:
- Publication type:
- Article
Marine enzymes and their potential.
- Published in:
- Drug Invention Today, 2010, v. 2, n. 9, p. 421
- By:
- Publication type:
- Article
PNIPAM Poly (N-isopropylacrylamide): A Thermoresponsive 'Smart' Polymer in Novel Drug Delivery Systems.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
PNIPAM Poly (N-isopropylacrylamide): A Thermoresponsive "Smart" Polymer in Novel Drug Delivery Systems.
- Published in:
- Internet Journal of Medical Update, 2012, v. 7, n. 2, p. 59
- By:
- Publication type:
- Article
Cancer Nanotechnology: Recent Trends and Developments.
- Published in:
- Internet Journal of Medical Update, 2011, v. 6, n. 1, p. 3, doi. 10.4314/ijmu.v6i1.63969
- By:
- Publication type:
- Article
Cancer Nanotechnology--- A Panacea.
- Published in:
- Internet Journal of Medical Update, 2010, v. 5, n. 1, p. 54
- By:
- Publication type:
- Article
Pharmacological Reversal of Histone Methylation Presensitizes Pancreatic Cancer Cells to Nucleoside Drugs: <i>In Vitro</i> Optimization and Novel Nanoparticle Delivery Studies.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0071196
- By:
- Publication type:
- Article
Chloroquine sensitizes MDA-MB-231 cells to osimertinib through autophagy–apoptosis crosstalk pathway.
- Published in:
- Breast Cancer: Targets & Therapy, 2019, v. 11, p. 231, doi. 10.2147/BCTT.S211030
- By:
- Publication type:
- Article
A quantitative systems pharmacological approach identified activation of JNK signaling pathway as a promising treatment strategy for refractory HER2 positive breast cancer.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2021, v. 48, n. 2, p. 273, doi. 10.1007/s10928-020-09732-x
- By:
- Publication type:
- Article
PK/PD and Bioanalytical Considerations of AAV-Based Gene Therapies: an IQ Consortium Industry Position Paper.
- Published in:
- AAPS Journal, 2023, v. 25, n. 5, p. 1, doi. 10.1208/s12248-023-00842-1
- By:
- Publication type:
- Article
Multiscale and Translational Quantitative Systems Toxicology, Pharmacokinetic-Toxicodynamic Modeling Analysis for Assessment of Doxorubicin-Induced Cardiotoxicity.
- Published in:
- AAPS Journal, 2021, v. 23, n. 1, p. 1, doi. 10.1208/s12248-020-00542-0
- By:
- Publication type:
- Article
In vitro to clinical translational pharmacokinetic/pharmacodynamic modeling of doxorubicin (DOX) and dexrazoxane (DEX) interactions: Safety assessment and optimization.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-29964-4
- By:
- Publication type:
- Article
Clinical Pharmacology Considerations for the "Off‐the‐Shelf" Allogeneic Cell Therapies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 6, p. 1233, doi. 10.1002/cpt.3241
- By:
- Publication type:
- Article
Clinical Pharmacology Perspective on Development of Adeno‐Associated Virus Vector‐Based Retina Gene Therapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 6, p. 1212, doi. 10.1002/cpt.3230
- By:
- Publication type:
- Article
An IQ Consortium Perspective on Best Practices for Bioanalytical and Immunogenicity Assessment Aspects of CAR‐T and TCR‐T Cellular Therapies Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 2, p. 188, doi. 10.1002/cpt.3111
- By:
- Publication type:
- Article
Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR‐T and TCR‐T Cell Therapies: An Industry Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 3, p. 530, doi. 10.1002/cpt.2986
- By:
- Publication type:
- Article
Model‐Based Cellular Kinetic Analysis of Chimeric Antigen Receptor‐T Cells in Humans.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 3, p. 716, doi. 10.1002/cpt.2040
- By:
- Publication type:
- Article
Bench‐to‐bedside translation of chimeric antigen receptor (CAR) T cells using a multiscale systems pharmacokinetic‐pharmacodynamic model: A case study with anti‐BCMA CAR‐T.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 4, p. 362, doi. 10.1002/psp4.12598
- By:
- Publication type:
- Article
Introduction to metallic nanoparticles.
- Published in:
- Journal of Pharmacy & Bioallied Sciences, 2010, v. 2, n. 4, p. 282, doi. 10.4103/0975-7406.72127
- By:
- Publication type:
- Article